News

January 16, 2020January 16, 2020

Cerevel Therapeutics Initiates Phase 3 Program Testing Tavapadon for Improved Motor Function

News

Cerevel Therapeutics announced its launch of a series of Phase 3 clinical trials to evaluate its investigational therapy tavapadon, designed to improve motor function in people with Parkinson’s disease. ... Read more

January 16, 2020January 17, 2020

Potential Oral Treatment Shows Promise in Early Study in Volunteers, Neuropore Says

News

A potential oral therapy for Parkinson’s disease and amyotrophic lateral sclerosis (ALS) was seen to be safe and well-tolerated at various doses in a Phase 1 trial in healthy volunteers, ... Read more

January 15, 2020January 15, 2020

Project Aiming to Create Working Neurons Awarded $4M Grant

News

A team of researchers at Purdue University won a $4 million grant from the National Science Foundation to advance the development of a synthetic neuron platform to support future ... Read more

January 15, 2020January 15, 2020

Biogen Acquires Pfizer’s PF-05251749, a Potential Disease-modifying Therapy for Parkinson’s, Alzheimer’s

News

Biogen is adding Pfizer’s PF-05251749 — a regulator of the body’s inner clock — to its group of potential disease-modifying therapies for Parkinson’s and Alzheimer’s diseases. Biogen plans to test ... Read more

January 14, 2020January 22, 2020

Affiris Announces Phase 2 Study of Potential Parkinson’s Vaccine

News

Affiris is preparing for a Phase 2 clinical trial to test Affitope (PD01A), an experimental medicine that, if successful, could lead to a vaccine against Parkinson’s disease. Affitope triggers the ... Read more

January 14, 2020January 14, 2020

One-year Results in 2 Given Gene Therapy at Low Dose Showing Promise, Axovant Reports

News

Two Parkinson’s patients treated with AXO-Lenti-PD, an investigative gene therapy, in an ongoing clinical trial continue to show improvement 12 months later, Axovant, the therapy’s developer, said in a release. ... Read more

January 13, 2020January 13, 2020

Awakening Dormant Neurons Could Provide Disease-modifying Parkinson’s Treatment, Early Study Suggests

News

Together with dying nerve cells, dormant neurons also may be at the root cause of Parkinson’s disease, according to a recent study in animal models. Reawakening these neurons by ... Read more

January 13, 2020January 13, 2020

First Patient Recruited for UK Study of Cholinesterase Inhibitors in Parkinson’s Disease

News

The first participant has been recruited for a clinical trial in the United Kingdom that will test whether a class of medicines used mainly for dementia can help prevent falls in Parkinson’s ... Read more

January 10, 2020January 10, 2020

Certain Impulse-Control Medications May Not Work for Parkinson’s Disease, Study Suggests

News

Medications used to manage impulse control disorders may not help Parkinson’s disease patients taking Mirapex (pramipexole) and Requip (ropinirole), and may even worsen their episodes, according to new research. ... Read more

January 10, 2020January 10, 2020

YOPD Advocates Raising Funds on Facebook to Send Participants to 2022 World Parkinson Congress

News

A group of young onset Parkinson’s disease (YOPD) patients from around the world are launching a yearlong Facebook fundraiser to help others with the disorder attend the 6th World ... Read more

Pin It on Pinterest